| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $132.1M | $134.0M | $180.2M |
| YoY Revenue Growth % | -1.4% | -25.7% | — |
| Gross Profit | $48.4M | $45.6M | — |
| Gross Margin % | 36.6% | 34.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $18.4M | $18.3M | $37.2M |
| Operating Margin % | 13.9% | 13.6% | 20.6% |
| Net Income (GAAP) | $18.3M | $28.2M | $29.6M |
| EBITDA (Normalized) | $25.2M | $23.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $41.7M | $36.5M | $8.0M |
| Capital Expenditures (CapEx) | $8.5M | $6.7M | — |
| Free Cash Flow (FCF) | $33.2M | $29.8M | $8.0M |
| FCF Margin % | 25.1% | 22.3% | 4.4% |
| Return on Invested Capital (ROIC %) | 14.8% | 13.1% | — |
| Cash & Short-Term Equivalents | $123.8M | $99.4M | — |
| Total Debt (Short + Long Term) | $26.0K | $70.3K | — |
| Total Stockholders' Equity | $221.7M | $210.0M | — |